Nausea and Flushing
Nausea and flushing are common side effects of Melanotan II, often occurring shortly after administration. These symptoms are generally mild but can be uncomfortable. Nausea is frequently reported, and flushing can cause noticeable redness in the skin. To mitigate these effects, users are advised to take the peptide with food. If nausea persists or worsens, discontinuation is recommended [Doc 1]. Nausea and flushing typically subside within a few hours, but persistent symptoms should be monitored closely.
Long Term Angiogenesis Risks
Melanotan II poses theoretical risks of promoting melanoma due to its stimulation of pigment cells. This risk arises from the peptide's ability to upregulate melanin production, potentially leading to abnormal cell proliferation. Although direct causal evidence is limited, the potential for melanoma development remains a significant concern [Doc 2]. Users should be vigilant for changes in moles or new skin growths, and discontinue use if such changes occur.
Systemic Toxicity and Rhabdomyolysis
Systemic toxicity, including rhabdomyolysis, is a severe side effect linked to Melanotan II. This condition involves muscle breakdown and can lead to kidney damage. Symptoms include muscle pain, weakness, and dark urine. Immediate medical attention is necessary if these symptoms appear. The risk of rhabdomyolysis underscores the importance of using Melanotan II with caution and under medical supervision [Doc 3]. Monitoring for muscle pain and changes in urine color is crucial for early detection.
Renal Infarction
Renal infarction, a rare but serious condition, has been associated with Melanotan II use. It involves the blockage of blood flow to the kidneys, leading to tissue damage. Symptoms include severe abdominal pain, nausea, and fever. This condition requires urgent medical intervention. The mechanism may involve thrombotic events or direct toxic effects on the kidneys [Doc 4]. Users experiencing severe abdominal pain should seek immediate medical evaluation.
Common & Rare Side Effects
| Side Effect | Severity | Likelihood | Note |
|---|---|---|---|
| Nausea | mild | common | Take dosage with food to minimize effects [Doc 1]. |
| Flushing | mild | common | Flushing typically subsides within hours [Doc 1]. |
| Rhabdomyolysis | very severe | rare | Seek immediate medical attention if muscle pain occurs [Doc 3]. |
| Renal Infarction | very severe | rare | Urgent medical evaluation needed for severe abdominal pain [Doc 4]. |
References & Citations
- [1]https://www.webmd.com/vitamins/ai/ingredientmono-884/melanotan
- [2]https://www.unsw.edu.au/newsroom/news/2023/01/what-is-melanotan-ii---the-drug-that-the-tga-urges-consumers-to-
- [3]https://pubmed.ncbi.nlm.nih.gov/23121206/
- [4]https://pmc.ncbi.nlm.nih.gov/articles/pmc7148395/
- [5]https://www.hpra.ie/safety-information/safety-notices/article/reminder-of-serious-health-risks-with-melanotan-2-self-tan-products